Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bruce Ryan Bistrian, Ph.D., M.D.

Co-Author

This page shows the publications co-authored by Bruce Bistrian and Kathleen Gura.
Connection Strength

0.703
  1. Effects of glucose or fat calories in total parenteral nutrition on fat metabolism and systemic inflammation in rats. Metabolism. 2011 Feb; 60(2):195-205.
    View in: PubMed
    Score: 0.111
  2. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006 Jul; 118(1):e197-201.
    View in: PubMed
    Score: 0.087
  3. Metabolic and Inflammatory Effects of an ?-3 Fatty Acid-Based Eucaloric Ketogenic Diet in Mice With Endotoxemia. JPEN J Parenter Enteral Nutr. 2019 11; 43(8):986-997.
    View in: PubMed
    Score: 0.054
  4. Redefining essential fatty acids in the era of novel intravenous lipid emulsions. Clin Nutr. 2018 06; 37(3):784-789.
    View in: PubMed
    Score: 0.047
  5. Update to A.S.P.E.N. position paper: clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2014 Dec; 29(6):841.
    View in: PubMed
    Score: 0.039
  6. The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism. 2015 Feb; 64(2):274-82.
    View in: PubMed
    Score: 0.038
  7. Parenteral nutrition intravenous fat emulsions product shortage considerations. Nutr Clin Pract. 2013 Aug; 28(4):528-9.
    View in: PubMed
    Score: 0.035
  8. A metabolomic analysis of two intravenous lipid emulsions in a murine model. PLoS One. 2013; 8(4):e59653.
    View in: PubMed
    Score: 0.035
  9. The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism. 2013 Apr; 62(4):499-508.
    View in: PubMed
    Score: 0.034
  10. A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions. Nutr Clin Pract. 2012 Apr; 27(2):150-92.
    View in: PubMed
    Score: 0.032
  11. Docosahexaenoic acid and arachidonic acid prevent essential fatty acid deficiency and hepatic steatosis. JPEN J Parenter Enteral Nutr. 2012 Jul; 36(4):431-41.
    View in: PubMed
    Score: 0.031
  12. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr. 2011 Sep; 94(3):749-58.
    View in: PubMed
    Score: 0.031
  13. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism. 2008 May; 57(5):698-707.
    View in: PubMed
    Score: 0.025
  14. Current clinical applications of omega-6 and omega-3 fatty acids. Nutr Clin Pract. 2006 Aug; 21(4):323-41.
    View in: PubMed
    Score: 0.022
  15. Current Clinical Applications of O-6 and O-3 Fatty Acids. Nutr Clin Pract. 2006 Aug; 21(4):323-341.
    View in: PubMed
    Score: 0.022
  16. Inhibition of matrix metalloproteinases increases PPAR-alpha and IL-6 and prevents dietary-induced hepatic steatosis and injury in a murine model. Am J Physiol Gastrointest Liver Physiol. 2006 Dec; 291(6):G1011-9.
    View in: PubMed
    Score: 0.022
  17. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg. 2005 Sep; 40(9):1446-53.
    View in: PubMed
    Score: 0.020
  18. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 Mar; 57(3):445-52.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.